Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in Behcet Patients With Arthritis
NCT01497717Phase 3Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Jul 2013
- Primary completion
- Oct 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in Behcet's disease (BD), sponsored by Rambam Health Care Campus. Started Jul 2013; status: completed.
02
Drugs
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT01497717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497717.